https://doi.org/10.4081/ltj.2022.298

ENDOLIFT® and multi-wavelength laser photobiomodulation: a randomized controlled trial study on 96 subjects, treating skin laxity of the lower third of the face

Vol. 29 No. 1 (2022)
Published: 30 June 2022
Endolift, laser therapy, skin laxity, face
Abstract Views: 3046
PDF: 1166
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Leonardo Longo
longo.leonardo@gmail.com
Institute Laser Medicine, International Academy for Laser Medicine and Surgery, Florence; e-Campus University, Milan, Italy.
Roberto Dell'Avanzato
e-Campus University, Milan; Aethtetic Medicine and Regenerative Centre, Zucchi Wellness Clinic, Monza, Italy.
Diego Longo
Institute Laser Medicine, International Academy for Laser Medicine and Surgery, Florence; University of Florence, Dept. of Physiology, Florence, Italy.

Background and aims: Many patients look for procedures that can achieve similar results to surgical lift avoiding the risks and possible complications of surgery. Endolift® and multi-wavelength (MW) laser photobiomodulation (PBM) are considered two of the most effective procedures in the treatment of skin laxity and superficial wrinkles. We aimed to investigate the reduction of skin laxity of the lower third of the face treated with the Endolift® technique alone or in combination with MW Laser PBM. Materials and Methods: From June 2016 to June 2018, 96 subjects (18 M; 78 F) were included in this randomized controlled trial (RCT) conducted in two Italian institutions. The area treated was the lower third of the face. The subjects were classified using the Ptosis Scale (grade I-V) at T0, with a Pinch Test <1.9 mm. We selected only subjects’ grade 4, both males and females, 45-55-years old. Thirty-two subjects (6M; 26F) (group 1) were treated with the Endolift® procedure followed by a session of MW Laser PBM using a simultaneous nonsurgical laser therapy emission of three different wavelengths (532 nm, 808 nm, 1064 nm). The MW Laser PBM was repeated after 7, 14 and 21 days. Thirty-two subjects (6M; 26F) (group 2) underwent only the Endolift® session. 32 subjects (6M; 26F) (group 3) received only MW Laser PBM. Follow up visits were performed at days 60 (T60), 120 (T120) and 540 (T540) after the treatments. The study ended in December 2019 when all the subjects had been followed for 18 months. Results: The results of the three groups were evaluated using the Ptosis Scale at T0, T60, T120 and T540. The combination of the two treatments (group 1) achieved more rapid effects, while MW Laser PBM alone treatment (group 3) achieved the slowest effect. The median test for independent samples showed that all the differences between groups are statistically significant at each follow-up (p=0.000). Conclusions: The Endolift® laser in the last 15 years allows to achieve exceptional results in the treatment of skin laxity reaching the desired ‘soft’ rejuvenation model which is increasingly desired. MW Laser PBM, in combination with Endolift®, obtains better results. Although significant at T540, the effects of MW Laser PBM alone are slower to reach.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Apfelberg DB, Rosenthal S, Hunstad JP, Achauer B, Fodor PB. Progress report on multicentre study of laser-assisted liposuction. Aesthetic Plast Surg. 1994 Summer; 18 (3): pp. 259-64. https://pubmed.ncbi.nlm.nih.gov/7976758/ DOI: https://doi.org/10.1007/BF00449791
http://www.fda.gov/consumer/updates/liposuction082007.html
Badin A, Moraes L, Gondek L, et al., Laser lipolysis: flaccidity under control. Aesthetic Plast Surg. 2002; 26: pp. 335-339. https://pubmed.ncbi.nlm.nih.gov/12432470/ DOI: https://doi.org/10.1007/s00266-002-1510-3
Dell’Avanzato R. Endolift® and soft laser resurfacing. In: XV Jornadas Mediterraneas de confrontaciones terapeuticas en medicina y cirurgia cosmetica; May 4-6, 2007; Sitges, Spain.
Scrimali L, Lomeo G, Dell’Avanzato R, Crippa A. Endolaser soft-lift: a new approach on body contouring. Perspectives and suggestions. Eur. J. Aesth. Med. Dermatol. 2013; 3 (3): pp. 86-90. https://bit.ly/3UTNcL4
Dell’Avanzato R. Endolift® Laser: Survey over 10 experienced Italian doctors. In: 38th Italian Society of Aesthetic Medicine Congress (SIME); May 12-14, 2017; Rome, Italy.
McGuff PE, Deterling RA, Jr, Gottlieb LS. Tumoricidal effect of laser energy on experimental and human malignant tumours. N Engl J Med 1965; 273: pp. 490-492. https://pubmed.ncbi.nlm.nih.gov/5318702/ DOI: https://doi.org/10.1056/NEJM196508262730906
Mester E, Szende B, Gartner P. The effect of laser beams on the growth of hair in mice. Radiobiol Radiother (Berl) 1968; 9: pp. 621-626. https://pubmed.ncbi.nlm.nih.gov/5732466/
Mester E, Ludany G, Selyei M, Szende B, Total GJ. The stimulating effect of low power laser rays on biological systems. Laser Rev. 1968; 1:3. https://pubmed.ncbi.nlm.nih.gov/3982191/
Longo L., Editor, Laser Manual of Medical Technology, OEO Publisher Firenze, 2014.
M. Hamblin, M.V. Pires De Sousa, T. Agrawal; Editors, Handbook of Low-Level Laser Therapy, Stamford Publisher, Boston, 2017. DOI: https://doi.org/10.1201/9781315364827
Longo L., Non-Surgical Laser in Aesthetic Medicine, in H. Teixeira Editor, Laser in Medicine and Surgery, Porto, 2017.
Meneghini F. Basic facial analysis. In: Meneghini F (Ed). Clinical facial analysis Elements, Principles, Techniques. Berlin: Springer; 2005. pp. 43-56.

How to Cite

Longo, L., Dell’Avanzato, R., & Longo, D. (2022). ENDOLIFT<sup>®</sup> and multi-wavelength laser photobiomodulation: a randomized controlled trial study on 96 subjects, treating skin laxity of the lower third of the face. Laser Therapy, 29(1), 115–120. https://doi.org/10.4081/ltj.2022.298
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.